Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/38430
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPapenfuss A.T.en
dc.contributor.authorLupat R.en
dc.contributor.authorLi J.en
dc.contributor.authorSchroeder J.en
dc.contributor.authorWall M.en
dc.contributor.authorPoortinga G.en
dc.contributor.authorCameron D.en
dc.contributor.authorBywater M.en
dc.contributor.authorKats L.en
dc.contributor.authorGearhart M.D.en
dc.contributor.authorBardwell V.J.en
dc.contributor.authorDickins R.A.en
dc.contributor.authorHannan R.D.en
dc.contributor.authorJohnstone R.W.en
dc.contributor.authorShortt J.en
dc.contributor.authorCraig S.en
dc.contributor.authorLefebure M.en
dc.contributor.authorTothill R.W.en
dc.contributor.authorKruse E.en
dc.contributor.authorHawkins E.D.en
dc.contributor.authorMatthews G.M.en
dc.contributor.authorGregory G.P.en
dc.contributor.authorMartin B.P.en
dc.contributor.authorKelly M.J.en
dc.contributor.authorTodorovski I.en
dc.contributor.authorDoyle M.A.en
dc.date.accessioned2021-05-14T13:06:46Zen
dc.date.available2021-05-14T13:06:46Zen
dc.date.copyright2017en
dc.date.created20170317en
dc.date.issued2017-03-17en
dc.identifier.citationNature Communications. 8 (no pagination), 2017. Article Number: 14581. Date of Publication: 06 Mar 2017.en
dc.identifier.issn2041-1723 (electronic)en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/38430en
dc.description.abstractThe Emu-Myc mouse is an extensively used model of MYC driven malignancy; however to date there has only been partial characterization of MYC co-operative mutations leading to spontaneous lymphomagenesis. Here we sequence spontaneously arising Emu-Myc lymphomas to define transgene architecture, somatic mutations, and structural alterations. We identify frequent disruptive mutations in the PRC1-like component and BCL6-corepressor gene Bcor. Moreover, we find unexpected concomitant multigenic lesions involving Cdkn2a loss and other cancer genes including Nras, Kras and Bcor. These findings challenge the assumed two-hit model of Emu-Myc lymphoma and demonstrate a functional in vivo role for Bcor in suppressing tumorigenesis.Copyright © 2017 The Author(s).en
dc.languageEnglishen
dc.languageenen
dc.publisherNature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom)en
dc.relation.ispartofNature Communicationsen
dc.titleGenomic characterisation of Emu-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1038/ncomms14581en
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid28262675 [http://www.ncbi.nlm.nih.gov/pubmed/?term=28262675]en
dc.identifier.source614675973en
dc.identifier.institution(Lefebure, Tothill, Kruse, Shortt, Gregory, Martin, Kelly, Todorovski, Doyle, Lupat, Li, Craig, Poortinga, Cameron, Bywater, Kats, Hannan, Papenfuss, Johnstone) Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia (Lefebure, Tothill, Kats, Papenfuss, Johnstone) Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia (Tothill) Department of Pathology, University of Melbourne, Parkville, VIC 3052, Australia (Hawkins, Schroeder, Papenfuss) Walter Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia (Shortt) School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Clayton, VIC 3168, Australia (Matthews) Dana Farber Cancer Institute, Boston, MA 02115, United States (Wall) Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Fitzroy, VIC 3065, Australia (Wall) Department of Medicine, St Vincent's Hospital, University of Melbourne, Parkville, VIC 3052, Australia (Gearhart, Bardwell) Developmental Biology Center, Masonic Cancer Center, Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN 55455, United States (Dickins) Australian Centre for Blood Diseases, Monash University, AMREP Building, Alfred Hospital, Commercial Road, Melbourne, VIC 3004, Australia (Hannan) Cancer Biology and Therapeutics Department, John Curtin School of Medical Research, Australian National University, Canberra Australian Capital Territory 0200, Australiaen
dc.description.addressR.W. Tothill, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia. E-mail: Richard.Tothill@petermac.orgen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2018 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailJohnstone R.W.; Ricky.Johnstone@petermac.org Tothill R.W.; Richard.Tothill@petermac.orgen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
crisitem.author.deptAllied Health-
crisitem.author.deptHaematology-
crisitem.author.deptPaediatric - Emergency-
Appears in Collections:Articles
Show simple item record

Page view(s)

28
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.